On January 11, 2016, venbio Select Advisor LLC filed a proxy statement soliciting proxies and urged the shareholders of Immunomedics Inc. to vote (1) for its nominees: Behzad Aghazadeh, Scott Canute, Peter Barton Hutt, and Khalid Islam for election as directors of the Company, (2) to vote against the Company’s advisory resolution on the compensation of its named executive officers, and (3) to vote against the approval of the amendment and restatement of the Company's certificate of incorporation, as amended, to increase the maximum number of authorized shares of the Company's capital stock at the Company’s annual meeting of shareholders scheduled to be held on February 16, 2016.